Levofloxacin Viatris

Levofloxacin, the active ingredient in Levofloxacin Viatris, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional.

GNH USA supplies Levofloxacin Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat infections caused by susceptible bacteria.

Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. Acute bacterial sinusitis: reduces sinus inflammation and clears infection. Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. Uncomplicated urinary tract infections: eliminates uropathogens and resolves dysuria. Skin and soft‑tissue infections: controls bacterial spread and promotes wound healing. Intra‑abdominal infections: targets mixed flora and supports recovery after surgery.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Abdominal pain - Insomnia

Serious or Rare Side Effects: - Tendon rupture or tendinitis - QT interval prolongation and cardiac arrhythmias - Clostridioides difficile‑associated colitis - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Peripheral neuropathy - Hepatic dysfunction or jaundice

Levofloxacin requires careful consideration of patient‑specific factors and proper handling.

Pregnancy: contraindicated because of potential fetal harm. Renal impairment: dose adjustment may be necessary to avoid accumulation. History of tendon disorders: avoid use due to risk of tendon rupture. Concurrent antacids or multivalent cations: may reduce drug absorption. Known hypersensitivity to fluoroquinolones: do not administer. Store at below 25°C: keep in the original pack, protect from moisture.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect, risk of bleeding. - Theophylline: elevated plasma concentrations, possible toxicity. - Other QT‑prolonging agents (e.g., ciprofloxacin, certain antiarrhythmics): additive cardiac risk. - Cyclosporine: increased cyclosporine levels, nephrotoxicity. - NSAIDs (high‑dose): heightened CNS stimulation and seizure risk.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Iron or zinc supplements: may lower bioavailability. - Diabetes medications (insulin, sulfonylureas): potential alteration of glucose control. - Corticosteroids: increased risk of tendon injury.